Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis

Cited 36 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorK Min-
dc.contributor.authorWoon Kee Yoon-
dc.contributor.authorS K Kim-
dc.contributor.authorB H Kim-
dc.date.accessioned2017-04-19T09:08:40Z-
dc.date.available2017-04-19T09:08:40Z-
dc.date.issued2007-
dc.identifier.issn0253-6269-
dc.identifier.uri10.1007/BF02980267ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/8189-
dc.description.abstractSilibinin is the major pharmacologically active compound of silymarin, the Silybum marianum fruit extract. Hepatoprotective activities of silibinin/silymarin are well-known, and recent studies demonstrated their anti-inflammatory and anti-carcinogenic effects which are due to inhibition of the transcription factor NF-κB. Based on this knowledge, we hypothesized that silibinin could be effective in the treatment of multiple sclerosis (MS) and so we tested its immunosuppressive effect in experimental autoimmune encephalomyelitis (EAE), the MS animal model. The process of spinal cord demyelination and inflammation were observed and T cell migration was determined by FACS analysis. The results showed that silibinin significantly reduced the histological signs of demyelination and inflammation in EAE. Since cytokines play an important role in inflammatory disease, the proliferative response and cytokine production were examined in lymphocytes from spleens and lymph nodes. We demonstrated that silibinin Agnonspecifically down-regulated the secretion of pro-inflammatory Th1 cytokines and up-regulated the anti-inflammatory Th2 cytokines in vitro. Silibinin also dose-dependently inhibited the production of Th1 cytokines ex vivo. These results indicate that silibinin is both immunosuppressive and immunomodulatory.-
dc.publisherPharmaceutical Soc Korea-
dc.titleImmunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis-
dc.title.alternativeImmunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis-
dc.typeArticle-
dc.citation.titleArchives of Pharmacal Research-
dc.citation.number10-
dc.citation.endPage1272-
dc.citation.startPage1265-
dc.citation.volume30-
dc.contributor.affiliatedAuthorK Min-
dc.contributor.affiliatedAuthorWoon Kee Yoon-
dc.contributor.alternativeName민경원-
dc.contributor.alternativeName윤원기-
dc.contributor.alternativeName김상금-
dc.contributor.alternativeName김봉희-
dc.identifier.bibliographicCitationArchives of Pharmacal Research, vol. 30, no. 10, pp. 1265-1272-
dc.identifier.doi10.1007/BF02980267-
dc.subject.keywordAE-
dc.subject.keywordCytokines-
dc.subject.keywordInflammation-
dc.subject.keywordMultiple sclerosis-
dc.subject.keywordSilibinin-
dc.subject.keywordT helper cells-
dc.subject.localAE-
dc.subject.localcytokine-
dc.subject.localCytokines-
dc.subject.localCytokine-
dc.subject.localinflammation-
dc.subject.localInflammation-
dc.subject.localMultiple sclerosis-
dc.subject.localmultiple sclerosis-
dc.subject.localsilibinin-
dc.subject.localSilibinin-
dc.subject.localT helper cells-
dc.subject.localT helper cell-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.